Clinical Trial Update: Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)

View source ↗

Summary

AstraZeneca reports a completed update for the HARRP program, which aims to harmonize randomized controlled trial emulations in a real-world replication for Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED